Prot#NN9536-4373: Effect and Safety of Semaglutide 2.4 mg Once-Weekly in Subjects with Overweight or Obesity

Project: Research project

Project Details

StatusActive
Effective start/end date6/29/186/29/21

Funding

  • DrugDev Inc. (Prot#NN9536-4373)
  • Novo Nordisk Inc. (Prot#NN9536-4373)